Cargando…
HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
SIMPLE SUMMARY: Breast cancer is the most prevalent type of cancer worldwide. By late 2020, there were 7.8 million women alive who had been diagnosed with breast cancer during the previous 5 years. HER2 overexpression in breast cancer is associated with poor prognosis. Existing HER2-targeting therap...
Autores principales: | Lopes, Cláudia, Piairo, Paulina, Chícharo, Alexandre, Abalde-Cela, Sara, Pires, Liliana R., Corredeira, Patrícia, Alves, Patrícia, Muinelo-Romay, Laura, Costa, Luís, Diéguez, Lorena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431641/ https://www.ncbi.nlm.nih.gov/pubmed/34503260 http://dx.doi.org/10.3390/cancers13174446 |
Ejemplares similares
-
Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma
por: Leitão, Tito Palmela, et al.
Publicado: (2023) -
Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
por: Carneiro, Adriana, et al.
Publicado: (2022) -
Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014) -
Droplet microfluidics for the highly controlled synthesis of branched gold nanoparticles
por: Abalde-Cela, Sara, et al.
Publicado: (2018) -
Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients
por: Ribeiro-Samy, Silvina, et al.
Publicado: (2019)